Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

THE ESTABLISHMENT OF cDNA MICROARRAY ABOUT PARTS OF SIGNAL TRANSDUCTION PATHWAY IN TREE SHREWS

[A Cdna Microarray Study of the Differential Expression of Genes in Signal Transduction Pathway During Hepatocarcinogenesis in Tree Shrews].

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

[Differentially Expressed Genes in Hepatocellular Carcinoma of Tree Shrew Induced by Different Factors].

Candidate genes responsible for human hepatocellular carcinoma identified from differentially expressed genes in hepatocarcinogenesis of the tree shrew (Tupaia belangeri chinesis).

ESTABLISHMENT OF TRANSGENE ANIMAL MODEL OF TREE SHREW WITH HBV X GENE BY USING THE SPERMATOGONIAL CELLS AS THE MEDIATING VECTOR

Differential Expression of Genes During Aflatoxin B(1)-induced Hepatocarcinogenesis in Tree Shrews.

Application of cDNA microarray in the mechanism analysis of drug

Cross-species Comparison of Smad3 Expression in Hepatocellular Carcinoma Tissues

Molecular cloning and characterization of NPC1L1 in the Chinese tree shrew (Tupaia belangeri chinensis)

Establishment and transcriptomic features of an immortalized hepatic cell line of the Chinese tree shrew

Identification of Key Genes in Hepatocellular Carcinoma and Validation of the Candidate Gene, Cdc25a, Using Gene Set Enrichment Analysis, Meta-Analysis and Cross-Species Comparison.

Expression of Bax and Bcl-2 As Well As Their Relationship with Cell Apoptosis During Hepatocarcinogenesis of Tree Shrews

Comprehensive Annotation of the Chinese Tree Shrew Genome by Large-Scale RNA Sequencing and Long-Read Isoform Sequencing.

Screening and identification of genes transactivated by C1 protein by microarray assay

The Application of Cdna Microarrays Technology in Mechanism of Drug

The Tree Shrew as a Model for Cancer Research

Identification of Candidate Diagnostic Tumor Markers for Human Hepatocellular Carcinoma Using Genechip Technology

Identification of SEC14 like lipid binding 2(SEC14L2) sequence and expression profiles in the Chinese tree shrew (Tupaia belangeri chinensis)

Screening the Human Pancreatic Cancer-Associated Genes by Cdna Microarray

Low expression of gene PTEN in human and tree shrew heptocellular carcinoma